Previous research has shown that the hepatoprotective effect of sulforaphane is associated with the suppression of cytochrome P450 enzymes (McCarty, 2001)
But where semaglutide acts on one receptor (the glucagon-like peptide-1, or GLP-1, receptor), and tirzepatide on two (GLP-1 and the gastric inhibitory polypeptide, or GIP, receptors), retatrutide has been nicknamed Triple G for its ability to work on three hormone receptors (those for GLP-1 and GIP, as well as the glucagon, or GCG, receptor)
Medical weight loss patients should also be willing to incorporate lifestyle changes for optimal results
We don't, because making sure these medications are safe for your body matters more to us than a quick prescription
J Exp Med
Ros own 12-month tirzepatide data at ObesityWeek 2025 showed 19.5% average loss